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ABSTRACT
Motivation: Many statistical tests have been proposed in recent
years for analyzing gene expression data in terms of gene sets,
usually from Gene Ontology. These methods are based on widely
different methodological assumptions. Some approaches test
differential expression of each gene set against differential expres-
sion of the rest of the genes, whereas others test each gene set on
its own. Also, some methods are based on a model in which the
genes are the sampling units, whereas others treat the subjects
as the sampling units. This article aims to clarify the assumptions
behind different approaches and to indicate a preferential methodo-
logy of gene set testing.
Results: We identify some crucial assumptions which are needed
by the majority of methods. P-values derived from methods that use
a model which takes the genes as the sampling unit are easily
misinterpreted, as they are based on a statistical model that does
not resemble the biological experiment actually performed.
Furthermore, because these models are based on a crucial and
unrealistic independence assumption between genes, the P-values
derived from such methods can be wildly anti-conservative,
as a simulation experiment shows. We also argue that methods that
competitively test each gene set against the rest of the genes create
an unnecessary rift between single gene testing and gene set testing.
Contact: j.j.goeman@lumc.nl
1 INTRODUCTION
A successful microarray experiment typically results in a long
list of differentially expressed genes. The gene list is usually
not the end point of the analysis; it is the starting point of a
complicated process of interpretation, in which the biologist
will search for patterns in the differential expression. A list of
differentially expressed genes is easier to interpret if the genes
exhibit similarity in their functional annotation or chromo-
somal location.
In recent years, many authors have proposed methods to
formalize this interpretation process using statistical hypothesis
tests. These methods group all genes that are annotated to the
same annotation term together into sets and analyze the result
of the microarray experiment in terms of these sets. This
essentially shifts the level of analysis of the microarray
experiment from single genes to sets of related genes. Such an
analysis allows biologists to make use of previously accumu-
lated biological knowledge in the analysis and makes a more
biology-driven analysis of microarray data possible. The
annotation terms are usually obtained from libraries such
as Gene Ontology (Ashburner et al., 2000) or KEGG
(Ogata et al., 1999). The sets of genes in this type of analysis
are always given a priori and are constructed without reference
to the data.
A great variety of methods has been proposed for testing
differential expression of a gene set with a single test. The most
popular method starts from the list of differentially expressed
genes and tests whether the gene set is overrepresented in this
list, using a test for independence in a 2 2 (contingency) table.
This approach has been described with minor variations by
many different authors (Al-Shahrour et al., 2004; Beissbarth
and Speed, 2004; Boyle et al., 2004; Hosack et al., 2003; Lee
et al., 2005; Pehkonen et al., 2005; Yi et al., 2006; Zeeberg et al.,
2003; Zhang et al., 2004, among others). See Khatri and
Dra˘ghici (2005) for an overview.
Other authors have criticized this approach because it
requires a strict cut-off for differential expression of indi-
vidual genes. As an alternative they have proposed methods
that use the whole vector of P-values. Breitling et al. (2004)
and Al-Shahrour et al. (2005) use the same 2 2 tables, but test
simultaneously at many cut-off values. Mootha et al. (2003) test
whether the ranks of the P-values of the genes in the gene
set differ from a uniform distribution, using a
weighted Kolmogorov–Smirnov test (see also Subramanian
et al., 2005). Pavlidis et al. (2004) use a test based on
the geometric mean of the P-values of the genes in the
gene set. Barry et al. (2005) provide a general framework for
post hoc testing based on P-values or other test statistics per gene.
A very different approach is used by a third group of
authors, who do not start from the P-values per gene, but from
the raw expression data. Goeman et al. (2004, 2005) test
whether subjects with similar gene expression profiles have
similar class labels, based on a logistic regression model.
Conversely, Mansmann and Meister (2005) test whether*To whom correspondence should be addressed.
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subjects with similar class labels have similar expression
profiles, based on an ANOVA model. Tomfohr et al. (2005)
use a t-test after reducing the gene set to its first principal
component.
Criticism of these methods in general has come from Khatri
and Dra˘ghici (2005) who pointed out limitations of the anno-
tation databases used. More fundamental criticism has been
given by Allison et al. (2006) who questioned the foundations
and the validity of some approaches.
This article addresses the questions raised by Allison et al.
(2006), identifying and investigating some fundamental
methodological differences that exist between gene set testing
methods. We do not want to compare all available methods, or
even to give a comprehensive account of all these methods. The
aim of this article is to discuss some important methodological
questions that arise when analyzing gene expression data in
terms of gene sets. We focus on two methodological issues on
which there is a clear disagreement. The first is the definition of
the null hypothesis; the second is the calculation of the P-value.
Concerning the definition of the null hypothesis, we make
a distinction between competitive and self-contained tests.
A competitive test compares differential expression of the gene
set to a standard defined by the complement of that gene set.
A self-contained test, in contrast, compares the gene set to a
fixed standard that does not depend on the measurements of
genes outside the gene set. The competitive test is most popular:
only Goeman et al. (2004, 2005), Mansmann and Meister
(2005) and Tomfohr et al. (2005) present self-contained tests.
Concerning the calculation of the P-value, we make a dis-
tinction between gene sampling methods and subject sampling
methods. The former bases the calculation of the P-value for
the gene set on a distribution in which the gene is the sampling
unit, while the latter takes the subject as the sampling unit. In
both cases, the sampling units are assumed to be independent
and identically distributed. Gene sampling methods are most
popular, with only Goeman et al. (2004, 2005), Mansmann and
Meister (2005), Mootha et al. (2003) and Tomfohr et al. (2005)
using subject sampling.
Because the focus of this article is not on details of specific
methods but on methodological issues, we do not compare
published methods (Dı´az-Uriarte, 2005; Manoli et al., 2006),
but we specifically construct methods that differ only with
respect to the issue at hand. This is done on the basis of the
2 2 table overrepresentation methods, because these are most
popular and easy to understand. The 2 2 table methods are
competitive and gene-sampling methods. For purposes of
comparison we will construct methods that are similar to the
2 2 table methods, except that they are self-contained, subject
sampling or both. Section 2 describes the 2 2 table methods.
Section 3 then studies competitive versus self-contained testing.
Section 4 compares gene sampling and subject sampling.
2 22 TABLE METHODS
The general idea of 2 2 table methods is to search for an
overrepresentation of the gene set among the differentially expressed
genes, or, equivalently, an overrepresentation of differentially expressed
genes among the genes in the gene set. There are minor differences in
the methods proposed by various authors (Khatri and Dra˘ghici, 2005),
but we give a general description here.
First, a measure of differential expression is calculated for each gene.
This is usually a P-value from a t-test or some other statistical test for
differential expression of single genes. It can also be a simple measure
such as fold change (Breitling et al., 2004). Next, a cut-off is found to
separate differentially expressed from non-differentially expressed
genes. This cut-off can be simple, such as the 100 genes with smallest
P-values, or it can be more sophisticated, e.g. based on a multiple
testing criterion such as Bonferroni or the false discovery rate
(Benjamini and Hochberg, 1995).
Given the list of differentially expressed genes and the list of genes in
the gene set, it is possible to fill a 2 2 table as indicated in Table 1.
The table simply counts the number of genes on the microarray with
every possible combination of the attributes ‘differentially expressed
(yes/no)’ and ‘in the gene set (yes/no)’.
The P-value for overrepresentation of the gene set among the
differentially expressed genes is subsequently calculated using a test for
independence in the 2 2 table of Table 1. A number of different tests
have been proposed for testing this independence, including the 2 test,
the hypergeometric test (Fisher’s exact test) and the binomial z-test for
proportions. Each of these tests is equivalent to a procedure that finds
the null distribution of a test statistic by randomly reassigning genes
to the labels for being in the gene set and for being differentially
expressed. The differences are in the choice of the test statistic and
whether the random reassignment is done with or without replacement.
These differences are not fundamental and tend to be unimportant
in practice (Khatri and Dra˘ghici, 2005). In this article we use the
hypergeometric test, which takes the size of the overlap between the
gene set and the list of differentially expressed genes as the test statistic,
and reassigns labels without replacement (i.e. it keeps the marginal
totals in the table constant).
3 COMPETITIVE VERSUS SELF-CONTAINED
TESTS
The main difference between competitive and self-contained
tests lies in the formulation of the null hypothesis. Loosely, the
null hypotheses can be formulated as follows. Let G be the gene
set of interest and Gc its complement, then the competitive null
hypothesis is
H comp0 : The genes in G are at most as often differentially
expressed as the genes in Gc,
while the self-contained null hypothesis is
H self0 : No genes in G are differentially expressed.
Note that these hypotheses refer to the number of truly
differentially expressed genes, not to the number of genes called
differentially expressed, even though the empirical numbers of
genes called differentially expressed will be used to test them.






In gene set mGD mGDc mG
Not in gene set mGcD mGcDc mGc
Total mD mDc m
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The hypothesis H self0 is almost invariably more restrictive
than H comp0 . The two null hypotheses are equivalent only in the
case that none of the genes in Gc are truly differentially
expressed, which is a highly unrealistic situation unless Gc is
very small. In general, truth of H self0 implies truth of H
comp
0 .
In this section, we discuss the merits of the two formulations
of the null hypotheses using the example of the 2 2 table
methods. To avoid the complicating issue of dependence of
genes, which will be covered in detail in Section 4, we assume
for simplicity that the P-values of all genes are independent.
The 2 2 table method tests the competitive null by
comparing the proportions of genes called differentially
expressed in G with the corresponding proportion in Gc, relying
on the reasonable assumption that a larger proportion of
truly differentially expressed genes in G will result in a higher
probability that a randomly chosen gene in G will be called
differentially expressed.
We can construct a self-contained counterpart of the 2 2
table method. This method tests H self0 with a binomial test
based on a test statistic m, which is the number of genes in G
with P-values smaller than . Under H self0 and assuming
independence of genes, m should have a binomial BðmG, Þ
distribution, where mG is the number of genes in G. Note that
this test, like its null hypothesis, is self-contained in the sense
that it does not use any information on genes in Gc. The
binomial test for the self-contained null hypothesis in a multiple
testing situation was first proposed by Tukey under the name of
higher criticism. It has recently been developed into a more
sophisticated method by Donoho and Jin (2004).
It is easy to compare the two procedures based on the two
different null hypotheses. There are a few remarks to be made.
Most of these have to do with the competitive nature of the
competitive null, which pits each gene set against its comple-
ment in what Allison et al. (2006) called a ‘zero-sum game’ (see
also Damian and Gorfine, 2004).
The first remark is about power. A test based on the self-
contained H self0 will almost invariably have more power than
a test based on the competitiveH comp0 . This follows immediately
from the fact that the self-contained null is more restrictive than
the competitive null, as noted above. As a consequence, a self-
contained test will almost always reject the null hypothesis for
more gene sets than a competitive null. This is especially the
case in a data set in which there are many differentially
expressed genes. In the competitive set-up, the significance of
the gene set G is ‘penalized’ for the significance of the gene
set Gc. Relative to the self-contained test, the competitive type
of test can be said to voluntarily relinquish some power in order
to make a stronger statement.
A second remark concerns the relationship between single
gene testing and gene set testing. It can easily be seen that for
a gene set containing only a single gene, Tukey’s higher
criticism will simply call the gene set significant whenever the
single gene’s P-value is below alpha. The self-contained test
is therefore an immediate generalization of single gene test-
ing to gene sets, in the sense that the two procedures are
completely equivalent for singleton gene sets. This is a desirable
property, which does not hold for the competitive test.
On the contrary, the competitive test treats a singleton gene
set very differently from a single gene, especially when there are
many differentially expressed genes in Gc.
Thirdly, it is interesting to look at the set of all genes on the
chip. This gene set cannot be tested in a competitive way,
simply because there is no complement to test the gene set
against. In contrast, the set of all genes can be a very useful
gene set to test with a self-contained test. It tests the global null
hypothesis that there are no differentially expressed genes.
Rejecting this null can be an interesting preliminary data
quality check, as a failure to reject this null leaves little hope
that anything can be found in the data. A self-contained test for
the set of all genes can also have a useful prediction
interpretation (Goeman et al., 2004).
The main objection that can be made against self-contained
testing, on the other hand, is that it can sometimes be too
powerful: in a situation in which there are many differentially
expressed genes almost all gene sets may be called significant.
Certainly, a direct application of Tukey’s higher criticism to
gene set testing in microarray data would lead to very large
power. However, this overly large power is for a large part due
to the strong independence assumption of the P-values that
this procedure requires. This independence assumption is the
subject of Section 4.
In the end, the issue of using a competitive or a self-contained
test should depend on the biological interpretation of the null
hypothesis. The self-contained null hypothesis that no gene
in the gene set is differentially expressed always has a clear
biological meaning. At the same time, it may not always be
biologically interesting, e.g. when comparing cancer versus
normal tissue: in such cases we may not expect the self-
contained null hypothesis to be true for any gene set. The
competitive null hypothesis on the other hand, although
sometimes more relevant, is much more difficult to test because
its definition is closely tied to a gene sampling model with
independent genes. The gene sampling model is the subject of
Section 4.
4 GENE VERSUS SUBJECT SAMPLING
The 2 2 table method and related methods are based on a
model which uses the gene as the sampling unit. This approach
is very different from the usual statistical setup, in which the
subjects are taken as the sampling units (Klebanov and
Yakovlev, 2006). It is instructive to compare the stochastic
models. This comparison shows enormous differences not only
in the assumptions underlying the respective models, but also in
the interpretation of the resulting P-values.
4.1 Gene-sampling and subject-sampling models
Classical statistical tests are based on a experimental design
that samples subjects. Each subject gets the same fixed set of
(gene expression) measurements. In the usual supervised
setting, the sample is assumed to consist of n independent
realizations (for the n subjects) of
ðX1,Y1Þ, . . . , ðXn,YnÞ, ð1Þ
where Xi is the m-dimensional vector of the expression
measurements of the ith subject, and Yi the corresponding
J.J.Goeman and P.Bu¨hlmann
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response variable (usually a class label, e.g. treatment versus
control). It is assumed that the n measurements of the different
subjects are independent and identically distributed, but that
different gene expression measurements within the same subject
may be correlated. A replication of the experiment under a
subject-sampling model would involve a new sample of
subjects, which are subjected to the same set of measurements,
i.e. the experiment is repeated for new subjects, but with the
same genes.
The model behind the 2 2 table methods is based on an
urn model which turns the classical statistical setup around.
The 2 2 table is filled with a sample of genes, each of which
is drawn at random from a big urn of genes. Each gene is
subjected to the same fixed set of two measurements. The first
measurement (A) indicates whether the gene is part of the gene
set or not; the second measurement (B) indicates whether the
gene is in the list of differentially expressed genes, based on the
P-value of that gene in the specific experiment performed.
The sample is assumed to consist of m observations (for the
m genes) of
ðA1,B1Þ, . . . , ðAm,BmÞ: ð2Þ
The test that is subsequently performed assumes that the
m measurements of the m different genes are all independent
and identically distributed.
Essentially, the gene-sampling urn model completely reverses
the roles of samples and genes relative to the classical statistical
setup. Instead of a sample of subjects which are given a fixed set
of measurements, we have a sample of measurements coming
from a fixed set of subjects. A replication of the experiment
under the urn model would therefore involve taking a new
sample of genes and subjecting these genes to the same
measurements, i.e. repeating the experiment for new genes
and the same subjects.
Note that the sample size is very different in the two setups.
The subject-sampling approach has sample size equal to the
number of subjects n, while the gene-sampling approach uses a
sample size equal to the number of genes m.
4.2 A subject-sampling 2 2 table method
For comparison we construct a subject-sampling analog to the
gene-sampling 2 2 table method. In general, this can be done
by calculating the P-value by subject permutation instead of
using the hypergeometric distribution, as proposed by Barry
et al. (2005) (and by Mootha et al., 2003, for GSEA). This
calculates a non-parametric permutation null distribution for
the null hypothesis that X and Y are independent, under the
assumption that ðX1,Y1Þ, . . . , ðXn,YnÞ are independent and
identically distributed. It is well known that for any test
statistic calculated from ðX1,Y1Þ, . . . , ðXn,YnÞ, its null distribu-
tion under these assumptions can be non-parametrically
computed by the distribution of the same test-statistic based
on ðX1,Yð1ÞÞ, . . . , ðXn,YðnÞÞ, where the distribution is gener-
ated from all (or many randomly generated) permutations
 : f1, . . . , ng ! f1, . . . , ng.
The subject-sampling analog of the hypergeometric test is
a subject permutation test based on the same test statistic that
the hypergeometric distribution uses, namely the overlap
mGD between the set of significant genes and the gene set
(see Table 1). Suppose that the data set has mD differentially
expressed genes, of which mGD are in the gene set of interest.
The algorithm is described in Table 2.
It should be noted that switching to subject permutation also
changes the null hypothesis that is tested. The subject
permutation null distribution is the complete null distribution
that no gene in G and Gc is differentially expressed, which is a
very specific case of the competitive null hypothesis, which is, in
fact, also a self-contained null hypothesis. The alpha level of the
test of Table 2 is guaranteed for the complete null hypothesis,
but is unclear for the competitive null hypothesis in general.
In a sense, the algorithm in Table 2 is a hybrid form between
gene sampling and subject sampling, as well as between
competitive and self-contained testing. The test statistic is
motivated by a gene-sampling model, but the P-value is
calculated using subject sampling. The test statistic is compe-
titive in the sense that it involves the genes in Gc, but the actual
null hypothesis tested is the complete null hypothesis, which
is both competitive and self-contained. A completely self-
contained and subject sampling alternative to the method of
Table 2 is given in Section 5.
Note also that permutation tests are not adequate in cases
where the subjects were not sampled according to the simple
sampling scheme given in (1), e.g. in time series or when
covariates are present. This means that a subject-sampling
equivalent of a specific 2 2 table method may not always
exist.
4.3 Interpretation of the P-value
The interpretation of a P-value greatly depends on the sampling
scheme on which the test is based. Because the gene-sampling
scheme is the mirror image of the subject-sampling scheme,
we will first review the interpretation of the classical subject
sampling P-value and derive the interpretation of the gene
sampling P-value by analogy.
The meaning of a P-value is related to hypothetical
replications of the experiment performed. By definition, if the
null hypothesis is true, no more than a fraction  of the
replications of an experiment will yield a P-value smaller than
. This property of the P-value is the basis of all statistical
inference based on it. However, as it is a statement about
replications of the experiment, its meaning and interpretation
are closely tied to the sampling scheme implied in the model.
In the classical subject-sampling setup, replications of the
experiment involve taking a new sample of subjects and
Table 2. A subject sampling alternative to the 2  2 table method
1. Permute the sample labels Y1 , . . . ,Yn N times.
2. For each permutation, recalculate the P-values for all genes based on
the permuted data.
3. For each vector of permutation P-values, count how many genes
in the gene set are among the mD genes with the smallest P-values.
Store these counts as k1 , . . . , kN.
4. Find the P-value of the gene set as the proportion of k1, . . . , kN
which are greater than mGD.
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measuring these subjects on the same variables. The interpreta-
tion of the P-value of a subject-sampling method therefore
relates to true biological replications of the experiment to new
subjects. A significant P-value excludes random variation at the
subject level as an explanation for the associations found, and
therefore gives confidence that the same associations will be
found for a new sample of subjects. On the other hand, the
subject-sampling P-value does not make any statement about
replications to new genes: if a Gene-Ontology term is
represented on a chip by only a single gene, a very significant
P-value for that singleton gene set does not say anything about
other genes from the same Gene-Ontology term.
In the gene-sampling setup, the roles of genes and samples
are reversed in the interpretation of the P-value. The
interpretation of the P-value relates to replications of the urn
experiment, which would take a new sample of genes and
calculate their P-values for the same subjects. A significant
P-value gives confidence that a similar association between the
variables ‘membership of the gene set’ and ‘being differentially
expressed’ will be found with these subjects on a new array with
different genes. However, the gene-sampling P-value does not
say anything about biological replications of the experiment
using different subjects.
This interpretation of the P-value of a gene-sampling method
can explain the radical claim made by Breitling et al. (2004).
They proposed iGA, a variant of the 2 2 table method that
bases the cut-off for differential expression of genes on fold
change instead of P-value, and simultaneously looks at all
possible choices of the cut-off. They claim that iGA even
produces valid P-values when used on a single two-color array.
In their abstract they write:
‘In the extreme, iGA can even produce statistically
meaningful results without any experimental replication.’
This statement is valid only in the context of the urn model.
A significant P-value of iGA only indicates that the specific
pair of subjects whose gene expression is measured on the two-
color array tends to have consistently high fold changes for the
genes in the gene set. However, this P-value does not say
anything about the next pair of subjects.
Just as in Section 3, it is instructive to look at the relationship
between gene set testing and single gene testing by considering
a single gene as a singleton gene set. If the statement made
about iGA were true, it would suddenly be possible to test for
differential expression of single genes without any experimental
replication by viewing the genes as singleton gene sets. This is
against all common sense. If single gene tests are always based
on a subject-sampling model, there is no real reason to base
gene set tests on a widely different model.
However, the most important problem with the gene-
sampling urn model is that it does not mimic the actual
biological experiment performed. A biological replication of the
experiment always takes a new sample of subjects, not a new
sample of genes. Biologists expect a P-value to measure the
strength of the evidence based on the biological experiment
actually performed and will interpret it in this context.
Calculating a P-value based on a gene-sampling urn model
can too easily lead to wildly misleading interpretations, and
should be discouraged in the strongest terms.
A related misleading aspect of the urn model is the apparent
sample size, which is equal to the number of genes m in that
model. This is not the same as the sample size of the biological
experiment, which is equal to the number of subjects n. The urn
model can therefore be seen as a model that artificially inflates
the sample size, resulting in inflated power. This increase in
power is not real, as it depends on a highly unrealistic
assumption of independence between genes. This is the subject
of Section 4.4.
4.4 The independence assumption
The gene-sampling model (2), on which all tests used in the
2 2 table methods are based, relies on the assumption that
the observations (Ai,Bi) for each gene are independent and
identically distributed. This is a highly unrealistic assumption
for gene expression data.
It is well known that strong correlations between genes occur
frequently in microarray data and that complete independence
between any two gene expression measurements is rare, if only
due to the presence of array effects. Correlations are especially
expected between functionally related genes. As gene sets to be
tested are usually chosen on the basis of functional annotation,
it should be expected that many of the genes in a tested gene set
are correlated.
Such correlations are problematic for tests used in 2 2 table
methods. Correlations between gene expression measurements
of genes tends to result in positive correlations between their
(two-tailed) P-values, which in turn causes their indicators Bi of
differential expression to be correlated. In turn, this results in
over-dispersion (see for example McCullagh and Nelder, 1989,
Ch. 4.5) for the number of genes called differentially expressed.
If P-values are positively correlated, the true null distribution of
the hypergeometric test is not hypergeometric, but has much
heavier tails. This can be understood by considering the
probability that two genes are both called differentially
expressed. This probability is much smaller when the genes
are independent than when the same genes have positively
correlated P-values. As a consequence, the use of the
hypergeometric test is anti-conservative; it may greatly under-
state the true P-values if the genes in the gene set are not
independent.
The anti-conservatism of the hypergeometric test may also
be understood in a different way. The null hypothesis of the
hypergeometric test assumes that the genes in the gene set are
not unusually often differentially expressed, but also that the
genes in the gene set are independent. Although designed to
detect the first kind of deviation from the null hypothesis, the
test also has power to detect the second. A significant result
from the hypergeometric test may therefore indicate unusual
differential expression of the genes in the gene set, but it may
also simply indicate that the genes are dependent.
To quantify the anti-conservativeness of the 2 2 table
method under dependence of genes, we conducted a small
simulation experiment, simulating data under the null hypoth-
eses with various degrees of dependence between genes. The
simulation setup was as follows. We varied a correlation
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coefficient  from 0 to 1 in steps of 0.1. For each value of , we
generated 5000 independent data sets. Each data set had 10 000
genes for 20 subjects. The genes were divided into 100 gene sets
of 100 genes each. Gene expression measurements were
generated independently for each subject according to
a multivariate normal distribution which had mean 0 and
variance 1 for each gene, and for which the correlation between
any two genes in the same gene set was taken equal to ,
while the correlation between genes of different gene sets was
taken as 0. The 20 subjects were divided into two groups of
10 each. The distribution of gene expression was independent of
the group indicator, so that none of the genes was in reality
differentially expressed.
On each data set, we performed a two-sided student t-test for
each gene under the (valid) assumption of equal variance. This
was followed up by a 2 2 table analysis for all gene sets based
on the hypergeometric test and on a cut-off for significance
of each t-test at 0.05. Together, this simulation setup gave a
collection of 500 000 gene set P-values for each value of , all
generated under the null hypothesis so that there is no dif-
ference in differential expression between gene sets. We counted
the number of rejections under various nominal -levels of the
hypergeometric test. The results are given in Table 3.
From the table we note that the hypergeometric test keeps
the -level for uncorrelated genes, as expected. For ¼ 0, the
test is even somewhat conservative due to the discrete nature of
the test. Despite this conservatism, the test already becomes
anti-conservative for very moderate correlations of 0.2–0.3,
depending on the -level. The anti-conservatism can grow to
rejection rates up to 50 000 times the nominal level for some
higher correlations and small -levels. It is most pronounced in
the tail of the distribution and for high correlations. The case
¼ 1 is an unrealistic but interesting extreme case in which all
100 genes in the gene set have the same expression, so that
either all or none are called differentially expressed. This
results in hypergeometric P-values of either (essentially) zero
or exactly 1, the former occurring with probability 0.05
(the -level of the original t-test), the latter with probability
0.95. Note that we focus especially on the extreme tail of the
distribution in Table 3, because that is the important part when
correcting for multiple testing. Similar anti-conservatism was
found by Breslin et al. (2004), who found that gene permutation
gave much smaller P-values than subject permutation in several
microarray data sets.
5 ADAPTING EXISTING METHODS
In the previous sections, we have studied the 2 2 table method
which tests a competitive null hypothesis on the basis of a gene-
sampling model. Using the 2 2 table methods as an example,
we have identified some important problems in competitive
methods as well as in gene-sampling methods. On the basis of
these we recommend to use methods which test a self-contained
null hypothesis and base the calculation of the P-value on a
subject-sampling model. There are two options for this.
The first option is to use one of the proposed gene set testing
methods that are based on classical statistical models, and
which by construction already test a self-contained null
hypothesis and calculate to P-value based on a subject-
sampling model that does not involve an independence
assumption of genes. Such methods have been proposed by
Goeman et al. (2004, 2005) based on the locally most powerful
test of Goeman et al. (2006), by Mansmann and Meister (2005)
based on an ANOVA model and by Tomfohr et al. (2005),
based on principal components. These methods do not proceed
Table 3. Fraction rejected for the 2 2 table method (standard hypergeometric test) for various nominal levels of , and for various degrees of
correlation among the genes in each gene set
Correlation  Nominal -level
0.1 0.05 0.01 0.001 0.0001 0.00001 0.000001
0 0.067 0.032 0.0061 0.00058 0.000036 0.000006 0.000000
0.1 0.068 0.033 0.0064 0.00061 0.000060 0.000006 0.000000
0.2 0.074 0.038 0.0088 0.0013 0.00023 0.000040 0.000012
0.3 0.094 0.058 0.022 0.0070 0.0028 0.0012 0.00058
0.4 0.12 0.088 0.047 0.023 0.013 0.0080 0.0050
0.5 0.15 0.12 0.078 0.049 0.033 0.024 0.018
0.6 0.17 0.14 0.10 0.075 0.057 0.046 0.037
0.7 0.17 0.15 0.12 0.097 0.080 0.067 0.058
0.8 0.16 0.15 0.13 0.11 0.094 0.084 0.075
0.9 0.14 0.13 0.12 0.10 0.095 0.088 0.083
1 0.050 0.050 0.050 0.050 0.050 0.050 0.050
The table is based on 500 000 simulated gene sets. All simulations are under the null hypothesis.
Table 4. Tuckey’ non-competitive subject sampling alternative to the
2 2 table method
1. Permute the sample labels Y1 , . . . , Yn N times.
2. For each permutation, recalculate the p-values for the genes in the
genes set.
3. For each vector of permutation p-values, count how many genes in
the gene set have p-value below . Store these counts as k1, . . . , kN.
4. Find the p-value of the gene set as the proportion of k1, . . . , kN which
are greater than mGD.
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in a post hoc fashion from the single gene P-values, but model
the gene expression data directly.
The second option is to adapt an existing post hoc method to
test a self-contained null hypothesis and to calculate the P-
value using subject sampling. Each of these adaptations has
already been demonstrated separately for the 2 2 table
method. We can combine the two adaptations into a combined
method, which is a subject-permutation version of Tukey’s
higher criticism. The algorithm is given in Table 4. Fix some 
beforehand and let mGD be the number of genes in the gene set
that have P-value below .
Other methods may be similarly adapted to a self-contained
null hypothesis and to subject sampling. An interesting method
in the context of adaptation is GSEA (Mootha et al., 2003;
Subramanian et al., 2005). This method uses a Kolmogorov–
Smirnov test statistic to test whether the ranks of the P-values
of the genes in the gene set can be a sample from a uniform
distribution. To calculate the P-value they use subject
permutation. This method is interesting because the
Kolmogorov–Smirnov test statistic is motivated by a gene-
sampling model, whereas a subject-sampling model is used for
calculating the P-value. In this sense the method is similar to
the hybrid method described in Section 4.2. It is interesting to
see that GSEA is sometimes found to have low power, as can be
seen from the GSEA user guide, which recommends 0.25 as the
most suitable FDR threshold (www.broad.mit.edu/gsea). This
low power may be due to the fact that the model and null
hypothesis used to motivate the test statistic are different from
the model and null hypothesis that are used when calculating the
P-value. GSEA can easily be transformed to a self-contained test
by calculating the Kolmogorov–Smirnov statistic on the basis of
the P-values themselves, instead of on their ranks.
The method of Pavlidis et al. (2004) takes the arithmetic
mean of the P-values as a test statistic per gene set and tests
this by using gene label permutation. Their method is gene
sampling and uses a competitive null, but it may easily be
transformed to a self-contained subject-sampling test by
switching from gene permutation to subject permutation.
6 DISCUSSION
This article has investigated methodological issues in methods
that test for differential expression of gene sets. It has revealed
some methodological aspects of popular methods that are
inefficient or even incorrect from a statistical point of view.
Although this article looked specifically at supervised methods
for gene set testing, similar problems occur in unsupervised
settings, for example when using a hypergeometric test for
testing overrepresentation of a GO term in a cluster of genes
from a cluster analysis.
We have given strong arguments against models that take the
genes as the independent sampling unit and therefore implicitly
or explicitly assume that the genes are independent. We have
argued that because the statistical model underlying these
P-values turns the actual experimental design on its head, the
interpretation of the P-value changes radically from the
traditional statistical one. This can easily lead to misunder-
standings and false conclusions. Furthermore, we have shown
that such tests do not give valid P-values when the genes on the
microarray are correlated. The P-values may easily be falsely
significant when the genes in the gene set are correlated, even
when none of the genes is truly differentially expressed. We
strongly recommend against the use of gene-sampling models in
gene set testing.
The issue of self-contained testing versus competitive testing
is closely connected to the issue of gene versus subject sampling.
A competitive null hypothesis is natural and easy to formulate
in a gene-sampling model, just as a self-contained null
hypothesis is natural in a subject-sampling model.
Methods for testing a self-contained null hypothesis are
all based on a subject-sampling model (Goeman et al., 2004,
2005; Mansmann and Meister, 2005; Tomfohr et al., 2005).
The classical statistical combination of a subject-sampling
model and a self-contained null hypothesis gives the advantage
of valid P-values, easy interpretability and a close relation
to single gene testing, as single gene testing is also based
on a self-contained null hypothesis and a subject-sampling
model.
Methods for testing a competitive null hypothesis are usually
based on a gene-sampling model and suffer from the same
validity problems as described for 2 2 table methods earlier.
A few methods such as GSEA (Mootha et al., 2003) and the
method of Table 2 (see also Barry et al., 2005) are hybrid in
the sense that they motivate their test statistic on the basis of
a gene-sampling model, but calculate their P-value in a subject-
sampling manner. The discrepancy between the two models
makes the statistical properties of the test unclear and its
interpretation difficult. These problems are unavoidable, as the
definition of the competitive null hypothesis is intimately tied to
the gene-sampling model, whereas valid P-values are easily
available for subject sampling only.
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